Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

92.42 +1.25 (+1.37%)
Official Closing Price Updated: 4:10 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Here Are The 5 Best Dow Jones Stocks So Far This Year Amid Market Sell-Off
Chevron is well off its June peak, but still the top blue chip stock this year. 
Via Investor's Business Daily
7 Beaten-Down S&P 500 Stocks to Buy Before They Rebound
With the market becoming more convinced that a "soft landing" is in the cards, there are many good, beaten-down S&P 500 stocks to buy. 
Via InvestorPlace
This Analyst Believes Seagen Is Evaluating Strategic Alternatives
 
Via Benzinga
What Are Whales Doing With Merck & Co
A whale with a lot of money to spend has taken a noticeably bullish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 11 strange trades. 
Via Benzinga
Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market
From Merck & Co., Inc.
Via Business Wire
8 Analysts Have This to Say About Merck & Co
Merck & Co (NYSE:MRK) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ
 
Via Benzinga
Merck to Hold Second-Quarter 2022 Sales and Earnings Conference Call July 28
From Merck & Co., Inc.
Via Business Wire
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
More than four in 10 people in a recent survey knew of someone with long Covid. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Merck To Start Pivotal Trial For Next-Gen Pneumococcal Vaccine Next Month
 
Via Benzinga
Tesla To $1,150? Here's The Biggest Price Target Changes For Monday
Evercore ISI Group cut United Airlines Holdings, Inc. (NASDAQ: UAL) price target from $56 to $45. United Airlines shares fell 0.8% to trade at $38.22 on Monday. 
Via Benzinga
LYNPARZA® (olaparib) Receives Positive Opinion From EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer
From Merck & Co., Inc.
Via Business Wire
EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies
 
Via Benzinga
3 Dow Stocks to Buy for a Bear Market
Investors can find safety from the bear market in these three Dow stocks. They offer low volatility, stable dividends and outperformance. 
Via InvestorPlace
Seagen Surges As Merck Takeover Deal Reportedly Accelerating
The news comes after ex-CEO Clay Siegall was arrested on domestic violence charges. 
Via Investor's Business Daily
Benzinga Before The Bell: Gun Safety Bill. Bill Gates's North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24
Reuters 
Via Benzinga
European Commission Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent Patients (≥12 Years of Age) With Stage IIB or IIC Melanoma Following Complete Resection
From Merck & Co., Inc.
Via Business Wire
Merck & Co Whale Trades For June 23
Someone with a lot of money to spend has taken a bearish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
6 Dividend Income Stocks With Better Yields Than the S&P 500
These 6 dividend income stocks outperformed the S&P this year and have higher yields, with earnings that can cover the dividends. 
Via InvestorPlace
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
CDC’s ACIP Unanimously Votes to Provisionally Recommend Use of Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) as an Option for Pneumococcal Vaccination in Infants and Children
From Merck & Co., Inc.
Via Business Wire
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in. 
Via InvestorPlace
U.S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children
From Merck & Co., Inc.
Via Business Wire
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
Via Benzinga
Results From Phase 3 PROpel Trial of LYNPARZA® (olaparib) Plus Abiraterone in First-Line Metastatic Castration-Resistant Prostate Cancer Published in NEJM Evidence
From Merck & Co., Inc.
Via Business Wire
Merck Announces that Chirfi Guindo will Lead Marketing for Merck Human Health
From Merck & Co., Inc.
Via Business Wire
SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal - What Investors Need To Know
SVB Securities conducted a pro-forma analysis of the financial impact to Merck & Co Inc (NYSE: MRK) from a potential acquisition of Seagen Inc (NASDAQ: SGEN). 
Via Benzinga
Tackling Recurring Health Conditions Offers Hope to Patients
Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly... 
Via FinancialNewsMedia
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.